Brenda Waning

1.0k total citations
13 papers, 527 citations indexed

About

Brenda Waning is a scholar working on Economics and Econometrics, Infectious Diseases and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Brenda Waning has authored 13 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Economics and Econometrics, 6 papers in Infectious Diseases and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Brenda Waning's work include Pharmaceutical Economics and Policy (9 papers), HIV/AIDS Research and Interventions (5 papers) and HIV/AIDS drug development and treatment (5 papers). Brenda Waning is often cited by papers focused on Pharmaceutical Economics and Policy (9 papers), HIV/AIDS Research and Interventions (5 papers) and HIV/AIDS drug development and treatment (5 papers). Brenda Waning collaborates with scholars based in United States, Netherlands and South Africa. Brenda Waning's co-authors include Richard Laing, Nathan Ford, Ellen ‘t Hoen, Andy Gray, Suerie Moon, Till Bärnighausen, Margaret Kyle, Yun Li, Elodie Jambert and Hubert G. M. Leufkens and has published in prestigious journals such as The Lancet, PLoS ONE and BMC Health Services Research.

In The Last Decade

Brenda Waning

13 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brenda Waning United States	8	321	132	128	84	69	13	527
Gabriela Costa Chaves Brazil	13	275 0.9×	52 0.4×	61 0.5×	119 1.4×	101 1.5×	33	606
Jacqui Miot South Africa	13	205 0.6×	90 0.7×	131 1.0×	134 1.6×	25 0.4×	50	540
Tido von Schoen-Angerer Switzerland	12	182 0.6×	71 0.5×	115 0.9×	95 1.1×	23 0.3×	40	568
Kim Ward South Africa	10	180 0.6×	77 0.6×	46 0.4×	87 1.0×	17 0.2×	17	333
Germán Velásquez Switzerland	9	160 0.5×	77 0.6×	23 0.2×	65 0.8×	44 0.6×	25	378
Francis Wafula Kenya	12	169 0.5×	213 1.6×	72 0.6×	133 1.6×	7 0.1×	37	484
Govin Permanand Denmark	13	176 0.5×	97 0.7×	52 0.4×	74 0.9×	12 0.2×	23	583
Eric Osei Ghana	12	121 0.4×	95 0.7×	164 1.3×	63 0.8×	15 0.2×	31	682
Tomasz Bochenek Poland	10	200 0.6×	53 0.4×	23 0.2×	65 0.8×	11 0.2×	28	366
Amani Thomas Mori Norway	12	119 0.4×	116 0.9×	47 0.4×	74 0.9×	8 0.1×	43	314

Countries citing papers authored by Brenda Waning

Since Specialization

Citations

This map shows the geographic impact of Brenda Waning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brenda Waning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brenda Waning more than expected).

Fields of papers citing papers by Brenda Waning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brenda Waning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brenda Waning. The network helps show where Brenda Waning may publish in the future.

Co-authorship network of co-authors of Brenda Waning

This figure shows the co-authorship network connecting the top 25 collaborators of Brenda Waning. A scholar is included among the top collaborators of Brenda Waning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brenda Waning. Brenda Waning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Martus, Peter, et al.. (2020). Quality assurance in anti-tuberculosis drug procurement by the Stop TB Partnership—Global Drug Facility: Procedures, costs, time requirements, and comparison of assay and dissolution results by manufacturers and by external analysis. PLoS ONE. 15(12). e0243428–e0243428. 6 indexed citations

Cox, Vivian, et al.. (2018). Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis. The International Journal of Tuberculosis and Lung Disease. 22(4). 407–412. 23 indexed citations

Bärnighausen, Till, Margaret Kyle, Joshua A. Salomon, & Brenda Waning. (2011). Assessing the population health impact of market interventions to improve access to antiretroviral treatment. Health Policy and Planning. 27(6). 467–476. 4 indexed citations

Waning, Brenda, et al.. (2010). Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets. Globalization and Health. 6(1). 9–9. 41 indexed citations

Waning, Brenda, et al.. (2010). Balancing medicine prices and business sustainability: analyses of pharmacy costs, revenues and profit shed light on retail medicine mark-ups in rural Kyrgyzstan. BMC Health Services Research. 10(1). 205–205. 6 indexed citations

Waning, Brenda, et al.. (2010). The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children. BMC Pediatrics. 10(1). 74–74. 26 indexed citations

Waning, Brenda, et al.. (2010). A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries. Journal of the International AIDS Society. 13(1). 35–35. 82 indexed citations

Waning, Brenda, et al.. (2010). Temporal Trends in Generic and Brand Prices of Antiretroviral Medicines Procured with Donor Funds in Developing Countries. Journal of Generic Medicines The Business Journal for the Generic Medicines Sector. 7(2). 159–175. 9 indexed citations

Waning, Brenda. (2009). Global strategies to reduce the price of antiretroviral medicines: evidence from transactional databases. Bulletin of the World Health Organization. 87(7). 520–528. 88 indexed citations

10.

Waning, Brenda, et al.. (2009). Towards equitable access to medicines for the rural poor: analyses of insurance claims reveal rural pharmacy initiative triggers price competition in Kyrgyzstan. International Journal for Equity in Health. 8(1). 43–43. 11 indexed citations

11.

Waning, Brenda & Taryn Vian. (2008). Transparency and Accountability in an Electronic Era: The Case of Pharmaceutical Procurements. BIBSYS Brage (BIBSYS (Norway)). 3 indexed citations

12.

Laing, Richard, Brenda Waning, Andy Gray, Nathan Ford, & Ellen ‘t Hoen. (2003). 25 years of the WHO essential medicines lists: progress and challenges. The Lancet. 361(9370). 1723–1729. 222 indexed citations

13.

Waning, Brenda, et al.. (2001). Pharmacoepidemiology: Principles and Practice. McGraw-Hill eBooks. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact